Target intelligence / Profile preview

microRNA 4797 (MIR4797)

Target
MIR4797
Molecular classification
MicroRNA, Non-coding RNA, Other (regulatory RNA)
01

Overview

microRNA 4797 (MIR4797) is a human microRNA gene that encodes a small non-coding RNA involved in regulation of gene expression by base pairing with complementary sequences in messenger RNAs, typically leading to translational repression or mRNA degradation[2][6]. Like other microRNAs, its dysregulation has been observed in cancer and may contribute to disease pathogenesis by affecting key cellular processes such as proliferation, apoptosis, and differentiation[3][4][5]. There is evidence that MIR4797 expression can be altered by DNA methylation or copy number variation in cancer, and it may serve as a molecular biomarker in the classification and prognosis of lower-grade glioma[1][3]. However, the precise mRNA targets, biological functions, and disease associations of MIR4797 specifically remain to be fully elucidated. No drugs are currently known to specifically interact with MIR4797, and it is not considered a conventional therapeutic target. The general structure, processing, and function of MIR4797 follow the paradigm for canonical human microRNAs[6].

Other names
hsa-mir-4797MIR4797microRNA 4797
02

Mechanism of action

no drugs directly target MIR4797; general mechanisms for miRNA therapeutics are antisense inhibition or miRNA mimics, but not reported for MIR4797

03

Biological functions

Gene expression regulation (via mRNA silencing or degradation; canonical microRNA function[2][6])Potential participation in cell cycle control, apoptosis, and differentiation (based on general microRNA roles, though not specifically confirmed for MIR4797[3][4][5])
04

Disease associations

Cancer (expression of many microRNAs, including MIR4797, is altered in malignancy; some studies report its association with tumor molecular subclasses, especially in glioma[1][3])Other (altered expression in disease states is a common feature of microRNAs and includes possible roles in immune regulation, but this is not established for MIR4797 specifically)
05

Safety considerations

no specific therapeutic targeting attempted, safety profile uncharacterized
06

Biomarkers

possible (microRNAs are experimentally used as diagnostic or prognostic biomarkers in cancer and other diseases; specific biomarker status for MIR4797 is not established but suggested in multi-omics glioma studies[1][3][5])

Beyond the preview

Go deeper on microRNA 4797 (MIR4797).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 4797 (MIR4797).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call